Efficacy of BRAF Inhibitors in Asian Metastatic Melanoma Patients: Potential Implications of Genomic Sequencing in BRAF-Mutated Melanoma12

Efficacy of BRAF Inhibitors in Asian Metastatic Melanoma Patients: Potential Implications of Genomic Sequencing in BRAF-Mutated Melanoma12

BACKGROUND: The BRAF inhibitors vemurafenib and dabrafenib are currently the standard treatment for metastatic melanoma with BRAF V600 mutations. However, given the rarity of noncutaneous melanoma, including acral and mucosal subtypes, the efficacy of BRAF inhibitors for this subset of patients has...

Full description

Bibliographic Details
Main Authors: Kim, Hee Kyung, Lee, Sunyoung, Kim, Kyung, Heo, Mi Hwa, Lee, Hansang, Cho, Jinhyun, Kim, Nayoung K.D., Park, Woongyang, Lee, Su Jin, Kim, Jung Han, Jang, Kee-Taek, Choi, Sang-Hee, Lee, Jeeyun
Format: Online
Language:English
Published: Neoplasia Press 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122709/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122709/

Similar Items